FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071754363> ?p ?o ?g. }

• W2071754363 endingPage "346" @default.
• W2071754363 startingPage "342" @default.
• W2071754363 abstract "The effect of topotecan, a topoisomerase I inhibitor, on ionizing radiation-induced cytotoxicity was studied in 2 human tumor cell lines characterized by a different expression of the target enzyme. The cytotoxicity of topotecan alone or in combination with radiation was assessed in exponentially growing non-small-cell lung cancer (H460) and glioblastoma (GBM) cells using the colony-forming assay. An isobologram method was used to evaluate the treatment interaction. An apparent supra-additive effect in cell killing following drug-radiation-combined treatment was observed only in GBM cells exposed to topotecan for 24 hr. In the case of H460 cells, interaction varied from a strong infra-additive effect at low radiation doses to a slight supra-additive effect when cells were exposed to radiation doses greater than 3 Gy. Northern blot analysis indicated that topoisomerase I expression in H460 cells was 8-fold higher than that of GBM cells. Although the H460 cell line exhibited an increased sensitivity to topotecan, only in the GBM cell line (which expressed a lower level of topoisomerase I) did the drug potentiate the radiation cytotoxicity. The observation that the radiosensitization by topotecan was related to topoisomerase I level is consistent with a putative role of the enzyme in processes involved in the repair of radiation damage. It is conceivable that the modulation of enzyme function results in an effective reduction of cellular capability for repair of radiation damage only if the enzyme is not over-expressed. Although a precise role of topoisomerase I in the cellular response to ionizing radiations (in particular, in DNA repair) remains to be documented, such results suggest the potential interest of topoisomerase I inhibitors in combination with radiation therapy for tumors expressing low topoisomerase I levels." @default.
• W2071754363 created "2016-06-24" @default.
• W2071754363 creator A5012989594 @default.
• W2071754363 creator A5022147301 @default.
• W2071754363 creator A5033312783 @default.
• W2071754363 creator A5048238411 @default.
• W2071754363 creator A5048820442 @default.
• W2071754363 creator A5062405463 @default.
• W2071754363 creator A5070863361 @default.
• W2071754363 creator A5089156584 @default.
• W2071754363 date "1996-05-03" @default.
• W2071754363 modified "2023-09-27" @default.
• W2071754363 title "Interaction of ionizing radiation with topotecan in two human tumor cell lines" @default.
• W2071754363 cites W1972483602 @default.
• W2071754363 cites W1975126215 @default.
• W2071754363 cites W1991068605 @default.
• W2071754363 cites W2000004469 @default.
• W2071754363 cites W2079571554 @default.
• W2071754363 cites W2082445456 @default.
• W2071754363 cites W2100837269 @default.
• W2071754363 doi "https://doi.org/10.1002/(sici)1097-0215(19960503)66:3<342::aid-ijc13>3.0.co;2-d" @default.
• W2071754363 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8621255" @default.
• W2071754363 hasPublicationYear "1996" @default.
• W2071754363 type Work @default.
• W2071754363 sameAs 2071754363 @default.
• W2071754363 citedByCount "44" @default.
• W2071754363 countsByYear W20717543632012 @default.
• W2071754363 countsByYear W20717543632016 @default.
• W2071754363 countsByYear W20717543632017 @default.
• W2071754363 crossrefType "journal-article" @default.
• W2071754363 hasAuthorship W2071754363A5012989594 @default.
• W2071754363 hasAuthorship W2071754363A5022147301 @default.
• W2071754363 hasAuthorship W2071754363A5033312783 @default.
• W2071754363 hasAuthorship W2071754363A5048238411 @default.
• W2071754363 hasAuthorship W2071754363A5048820442 @default.
• W2071754363 hasAuthorship W2071754363A5062405463 @default.
• W2071754363 hasAuthorship W2071754363A5070863361 @default.
• W2071754363 hasAuthorship W2071754363A5089156584 @default.
• W2071754363 hasConcept C109316439 @default.
• W2071754363 hasConcept C111337013 @default.
• W2071754363 hasConcept C121332964 @default.
• W2071754363 hasConcept C126322002 @default.
• W2071754363 hasConcept C147897179 @default.
• W2071754363 hasConcept C1491633281 @default.
• W2071754363 hasConcept C153911025 @default.
• W2071754363 hasConcept C181199279 @default.
• W2071754363 hasConcept C18231593 @default.
• W2071754363 hasConcept C185544564 @default.
• W2071754363 hasConcept C185592680 @default.
• W2071754363 hasConcept C202751555 @default.
• W2071754363 hasConcept C206684579 @default.
• W2071754363 hasConcept C26114605 @default.
• W2071754363 hasConcept C2776694085 @default.
• W2071754363 hasConcept C2778616834 @default.
• W2071754363 hasConcept C2781209748 @default.
• W2071754363 hasConcept C502942594 @default.
• W2071754363 hasConcept C509974204 @default.
• W2071754363 hasConcept C54355233 @default.
• W2071754363 hasConcept C55493867 @default.
• W2071754363 hasConcept C71924100 @default.
• W2071754363 hasConcept C81885089 @default.
• W2071754363 hasConcept C86803240 @default.
• W2071754363 hasConcept C98274493 @default.
• W2071754363 hasConceptScore W2071754363C109316439 @default.
• W2071754363 hasConceptScore W2071754363C111337013 @default.
• W2071754363 hasConceptScore W2071754363C121332964 @default.
• W2071754363 hasConceptScore W2071754363C126322002 @default.
• W2071754363 hasConceptScore W2071754363C147897179 @default.
• W2071754363 hasConceptScore W2071754363C1491633281 @default.
• W2071754363 hasConceptScore W2071754363C153911025 @default.
• W2071754363 hasConceptScore W2071754363C181199279 @default.
• W2071754363 hasConceptScore W2071754363C18231593 @default.
• W2071754363 hasConceptScore W2071754363C185544564 @default.
• W2071754363 hasConceptScore W2071754363C185592680 @default.
• W2071754363 hasConceptScore W2071754363C202751555 @default.
• W2071754363 hasConceptScore W2071754363C206684579 @default.
• W2071754363 hasConceptScore W2071754363C26114605 @default.
• W2071754363 hasConceptScore W2071754363C2776694085 @default.
• W2071754363 hasConceptScore W2071754363C2778616834 @default.
• W2071754363 hasConceptScore W2071754363C2781209748 @default.
• W2071754363 hasConceptScore W2071754363C502942594 @default.
• W2071754363 hasConceptScore W2071754363C509974204 @default.
• W2071754363 hasConceptScore W2071754363C54355233 @default.
• W2071754363 hasConceptScore W2071754363C55493867 @default.
• W2071754363 hasConceptScore W2071754363C71924100 @default.
• W2071754363 hasConceptScore W2071754363C81885089 @default.
• W2071754363 hasConceptScore W2071754363C86803240 @default.
• W2071754363 hasConceptScore W2071754363C98274493 @default.
• W2071754363 hasIssue "3" @default.
• W2071754363 hasLocation W20717543631 @default.
• W2071754363 hasLocation W20717543632 @default.
• W2071754363 hasOpenAccess W2071754363 @default.
• W2071754363 hasPrimaryLocation W20717543631 @default.
• W2071754363 hasRelatedWork W1620348927 @default.
• W2071754363 hasRelatedWork W1976810488 @default.
• W2071754363 hasRelatedWork W1985729303 @default.
• W2071754363 hasRelatedWork W1995556774 @default.
• W2071754363 hasRelatedWork W2017739390 @default.

• next